---
document_datetime: 2023-09-21 20:56:32
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/leganto-epar-all-authorised-presentations_en.pdf
document_name: leganto-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.2159266
conversion_datetime: 2025-12-22 09:31:48.749339
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength            | Pharmaceutical Form       | Route of Administration   | Immediate Packaging                                                                                                              | Pack size                       |
|------------------|-------------------|---------------------|---------------------------|---------------------------|----------------------------------------------------------------------------------------------------------------------------------|---------------------------------|
| EU/1/11/695/001  | Leganto           | 1 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper) PE/Alu/ ET copolymer/paper) PE/Alu/ET copolymer/paper) authorised | 7 patches                       |
| EU/1/11/695/003  | Leganto           | 1 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 28 patches                      |
| EU/1/11/695/004  | Leganto           | 1 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer                                                                                              | 30 patches                      |
| EU/1/11/695/007  | Leganto           | 1 mg/24 h           | Transdermal patch         | Transdermal use longer    | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 84 (2 x 42) patches (multipack) |
| EU/1/11/695/010  | Leganto           | 2 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 7 patches                       |
| EU/1/11/695/012  | Leganto           | 2 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 28 patches                      |
| EU/1/11/695/013  | Leganto           | 2 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 30 patches                      |
| EU/1/11/695/016  | Leganto           | 2 mg/24 h           | Transdermal patch no      | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 84 (2 x 42) patches (multipack) |
| EU/1/11/695/019  | Leganto           | 3 mg/24 h           | Transdermal patch product | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 7 patches                       |
| EU/1/11/695/021  | Leganto           | 3 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 28 patches                      |
| EU/1/11/695/022  | Leganto           | 3 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 30 patches                      |
| EU/1/11/695/025  | Leganto           | 3 mg/24 h Medicinal | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 84 (2 x 42) patches (multipack) |
| EU/1/11/695/028  | Leganto           | 4 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                                                   | 7 patches                       |
| EU/1/11/695/030  | Leganto           | 4 mg/24 h           | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer                                                                                              | 28 patches                      |
| EU/1/11/695/031  | Leganto           | 4 mg/24 h           | Transdermal patch         | Transdermal use           | PE/Alu/ET copolymer/paper) sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                        | 30 patches                      |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form       | Route of Administration   | Immediate Packaging                                                                                  | Pack size                                                           |
|------------------|-------------------|------------|---------------------------|---------------------------|------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------|
| EU/1/11/695/034  | Leganto           | 4 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper) PE/Alu/ET copolymer/paper) authorised | 84 (2 x 42) patches (multipack)                                     |
| EU/1/11/695/037  | Leganto           | 6 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 7 patches                                                           |
| EU/1/11/695/039  | Leganto           | 6 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer                                                                  | 28 patches                                                          |
| EU/1/11/695/040  | Leganto           | 6 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer                                                                  | 30 patches                                                          |
| EU/1/11/695/043  | Leganto           | 6 mg/24 h  | Transdermal patch         | Transdermal use longer    | PE/Alu/ET copolymer/paper) sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)            | 84 (2 x 42) patches (multipack)                                     |
| EU/1/11/695/046  | Leganto           | 8 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 7 patches                                                           |
| EU/1/11/695/048  | Leganto           | 8 mg/24 h  | Transdermal patch         | Transdermal use no        | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 28 patches                                                          |
| EU/1/11/695/049  | Leganto           | 8 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 30 patches                                                          |
| EU/1/11/695/052  | Leganto           | 8 mg/24 h  | Transdermal patch         | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 84 (2 x 42) patches (multipack)                                     |
| EU/1/11/695/055  | Leganto           | --         | Transdermal patch product | Transdermal use           | sachet (paper/LDPE/alu/ET copolymer PE/Alu/ET copolymer/paper)                                       | 28 patches (7 x 2 mg/24h, 7 x 4 mg/24h, 7 x 6 mg/24h, 7 x 8 mg/24h) |

Medicinal product no longer authorised